Literature DB >> 32051611

Salvage therapy at biochemical recurrence of prostate cancer.

Nicholas G Zaorsky1,2, Amar U Kishan3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32051611     DOI: 10.1038/s41585-020-0290-3

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401).

Authors:  Akira Yokomizo; Masashi Wakabayashi; Takefumi Satoh; Katsuyoshi Hashine; Takahiro Inoue; Kiyohide Fujimoto; Shin Egawa; Tomonori Habuchi; Kiyotaka Kawashima; Osamu Ishizuka; Nobuo Shinohara; Mikio Sugimoto; Yasushi Yoshino; Keiji Nihei; Haruhiko Fukuda; Ken-Ichi Tobisu; Yoshiyuki Kakehi; Seiji Naito
Journal:  Eur Urol       Date:  2019-12-19       Impact factor: 20.096

  1 in total
  1 in total

1.  MAGE-C2/CT10 promotes growth and metastasis through upregulating c-Myc expression in prostate cancer.

Authors:  Jun Qiu; Bei Yang
Journal:  Mol Cell Biochem       Date:  2020-07-06       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.